Laurus labs has completed its quarterly regulatory filing by submitting the mandatory certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026. The submission was made to both major stock exchanges on April 15, 2026.

Regulatory Compliance Details

The company submitted the required documentation to fulfill its obligations under SEBI regulations. The certificates were issued by KFin Technologies Limited, which serves as the Registrar and Share Transfer Agent for Laurus Labs Limited.

Stock Exchange Notifications

The certificates were submitted to both primary stock exchanges where the company's shares are traded:

• BSE Limited: Submitted to Corporate Relations Department at Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai
• National Stock Exchange of India Limited: Submitted to Listing Department at Exchange Plaza, Bandra Kurla Complex, Mumbai

Depository Certifications

KFin Technologies Limited issued separate certificates to both major depositories on April 2, 2026:

Certificate Confirmation

The certificates confirm that all details of securities dematerialized and rematerialized during the quarter ended March 31, 2026 have been properly furnished to all stock exchanges where Laurus Labs Limited shares are listed. This certification ensures compliance with SEBI (Depositories and Participants) Regulations 2018.

The regulatory filing demonstrates the company's commitment to maintaining transparency and adhering to all prescribed compliance requirements as mandated by securities market regulations.

Laurus Labs has announced that it will host a conference call to discuss its Q4 and Full Year FY26 results on April 30, 2026, at 5:00 PM IST. The pharmaceutical company made this announcement on April 09, 2026, providing stakeholders with an opportunity to engage in an interactive discussion about the company's financial performance.

Conference Call Details

The earnings conference call will be hosted by DAM Capital Advisors and will feature a comprehensive discussion of the quarterly and annual results followed by an interactive Q&A session. The company has arranged multiple dial-in options to accommodate participants from various geographical locations:

Board Meeting and Financial Results

Prior to the conference call, the company's Board of Directors will meet on the same day to consider and approve the audited financial results for the quarter and year ended March 31, 2026. The board will also deliberate on a second interim dividend payment for FY 2025-26 and fix the record date for shareholder eligibility.

Regulatory Compliance

The announcement was made in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has also implemented a trading window closure for its directors and designated persons from April 01, 2026, to May 02, 2026, ensuring adherence to insider trading regulations.

Contact Information

For investor-related queries, stakeholders can reach out to Vivek Kumar at +91 40 3980 4366 or via email at investorrelations@lauruslabs.com . Media relations are handled by Karthik C, who can be contacted at +91 40 3980 4380 or mediarelations@lauruslabs.com .

The company secretary and compliance officer, G. Venkateswar Reddy, has signed the official communication to both BSE Limited (Code: 540222) and National Stock Exchange of India Ltd. (Code: LAURUSLABS), ensuring full transparency and regulatory compliance.